Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Automated Single to Multichannel Pipetting Platform Includes Unique Deck

By LabMedica International staff writers
Posted on 21 Oct 2013
A new, compact liquid handling platform for high precision single to multichannel pipetting provides enhanced flexibility with a unique deck design and a selection of accessories. More...


Based on 25 years of experience in precision liquid handling to support a broad range of applications, CyBio AG (Jena, Germany) has designed the new “CyBi-FeliX” to offer a more flexible and compact automated liquid handling platform. On a footprint of only 650 x 650 x 450 mm (W x H x D) to fit almost any benchtop, its unique deck design offers 12 positions on two levels for microplates, tube racks, reservoirs and tips. Also available is a selection of optional accessories such as tip wash station and microplate heating-cooling.

The platform can be adjusted to meet a wide variety of application requirements through appropriate combination of pipetting heads and accessories any time. For reliable precision in the required applications, choose between the interchangeable 96-/384-channel pipetting heads (e.g., for whole microplate processing) and the “CHOICE” pipetting head with a unique volume range of 500 nL to 1 mL. Along with the parallel processing of whole 96- and 384-well microplates, the CyBi-FeliX also allows to work in single wells, rows, and columns without the need for manual intervention, and provides format flexibility with automatic loading of adapters and tips.

The CyBi-FeliX is a highly suitable precision platform for a wide variety of automated liquid handling laboratory tasks such as filling of plates and tubes, creating reaction set-ups for PCR and sequencing, ELISA, hit picking or pooling of samples, and serial dilutions.

Related Links:

CyBio AG





Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.